Treatment of Hypertension and Renal Injury Induced by the Angiogenesis Inhibitor Sunitinib Preclinical Study

Lankhorst, S.; Kappers, M.H.W.; Esch, J.H.M. van; Smedts, F.M.M.; Sleijfer, S.; Mathijssen, R.H.J.; ... ; Meiracker, A.H. van den (2014)

Article / Letter to editor

• acute renal injury
• endothelin-1
• hypertension
• sunitinib
• therapeutics
• vascular endothelial growth factor A

• All authors: Lankhorst, S.; Kappers, M.H.W.; Esch, J.H.M. van; Smedts, F.M.M.; Sleijfer, S.; Mathijssen, R.H.J.; Baelde, H.J.; Danser, A.H.J.; Meiracker, A.H. van den
• Date: 2014-12-31
• Journal: Hypertension
• Volume: 64
• Issue: 6
• Pages: 1282 - U260
• DOI: doi:10.1161/HYPERTENSIONAHA.114.04187